{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:49:04Z","timestamp":1794386944648,"version":"4.9.0"},"publisher-location":"Vienna","reference-count":34,"publisher":"Springer Vienna","isbn-type":[{"value":"9783211837962","type":"print"},{"value":"9783709161395","type":"electronic"}],"license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002]]},"DOI":"10.1007\/978-3-7091-6139-5_19","type":"book-chapter","created":{"date-parts":[[2011,4,27]],"date-time":"2011-04-27T06:14:51Z","timestamp":1303884891000},"page":"203-216","source":"Crossref","is-referenced-by-count":23,"title":["Nicotinic receptor modulation: Advantages for successful Alzheimer\u2019s disease therapy"],"prefix":"10.1007","author":[{"given":"H.","family":"Geerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Finkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Spiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"19_CR1","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1111\/j.1460-9568.1997.tb01702.x","volume":"9","author":"M Alkondon","year":"1997","unstructured":"Alkondon M, Pereira EF, Cortes WS, Maelicke A, Albuquerque EX (1997) Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur J Neurosci 9: 2734\u20132742","journal-title":"Eur J Neurosci"},{"key":"19_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/0896-6273(94)90331-X","volume":"12","author":"L Anglister","year":"1994","unstructured":"Anglister L, Stiles JR, Salpeter MM (1994) Acetylcholinesterase density and turnover number at frog neuromuscular junctions, with modeling of their role in synaptic function. Neuron 12: 783\u2013794","journal-title":"Neuron"},{"key":"19_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1085\/jgp.112.2.181","volume":"112","author":"A Auerbach","year":"1998","unstructured":"Auerbach A, Akk G (1998) Desensitization of mouse nicotinic acetylcholine receptor channels. A two-gate mechanism. J Gen Physiol 112:181\u2013197","journal-title":"J Gen Physiol"},{"key":"19_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1006\/exnr.2000.7397","volume":"163","author":"RT Bartus","year":"2000","unstructured":"Bartus RT (2000) On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163: 495\u2013529","journal-title":"Exp Neurol"},{"key":"19_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000051229","volume":"1","author":"R Blesa","year":"2000","unstructured":"Blesa R (2000) Galantamine: therapeutic effects beyond cognition. Dement Geriatr Cogn Disord ll[Suppl 1]: 28\u201334","journal-title":"Dement Geriatr Cogn Disord"},{"key":"19_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/brain\/99.3.459","volume":"99","author":"DM Bowen","year":"1976","unstructured":"Bowen DM, Smith CB, White P, Davison AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99: 459\u2013496","journal-title":"Brain"},{"key":"19_CR7","unstructured":"Understanding nicotinic receptor modulation in AD therapy 215"},{"key":"19_CR8","doi-asserted-by":"crossref","first-page":"7880","DOI":"10.1523\/JNEUROSCI.16-24-07880.1996","volume":"16","author":"B Buisson","year":"1996","unstructured":"Buisson B, Gopalakrishnan M, Arneric SP, Sullivan JP, Bertrand D (1996) Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: a patch-clamp study. J Neurosci 16: 7880\u20137891","journal-title":"J Neurosci"},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0006-3223(00)01116-1","volume":"49","author":"J Court","year":"2001","unstructured":"Court J, Martin-Ruiz C, Piggott M, Spurden D, Griffiths M, Perry E (2001) Nicotinic receptor abnormalities in Alzheimer\u2019s disease. Biol Psychiatry 49: 175\u2013184","journal-title":"Biol Psychiatry"},{"key":"19_CR10","doi-asserted-by":"crossref","unstructured":"Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer\u2019s disease. Lancet ii: 1403","DOI":"10.1016\/S0140-6736(76)91936-X"},{"key":"19_CR11","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/jama.281.15.1401","volume":"281","author":"KL Davis","year":"1999","unstructured":"Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V (1999) Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 281: 1401\u20131406","journal-title":"JAMA"},{"key":"19_CR12","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1523\/JNEUROSCI.21-12-04125.2001","volume":"21","author":"KT Dineley","year":"2001","unstructured":"Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD (2001) Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer\u2019s disease. J Neurosci 21: 4125\u20134133","journal-title":"J Neurosci"},{"key":"19_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0896-6273(01)00418-4","volume":"31","author":"A Elhamdani","year":"2001","unstructured":"Elhamdani A, Palfrey HC, Artalejo CR (2001) Quantal size is dependent on stimulation frequency and calcium entry in calf chromaffin cells. Neuron 31: 819\u2013830","journal-title":"Neuron"},{"key":"19_CR14","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1523\/JNEUROSCI.21-20-07993.2001","volume":"21","author":"R Fabian-Fine","year":"2001","unstructured":"Fabian-Fine R,Skehel P,Errington ML,Davies HA, Sher E, Stewart MG,Fine A (2001) Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus.J Neurosci 21: 7993\u20138003","journal-title":"J Neurosci"},{"key":"19_CR15","first-page":"3541","volume":"276","author":"T Kihara","year":"2001","unstructured":"Kihara T., Shimohama S., Sawada H., Honda K., Nakamizo T., Shibasaki H., Kume T., Akaike A. (2001) alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J Biol Chem 276: 3541\u201313546","journal-title":"J Physiol"},{"key":"19_CR16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1113\/jphysiol.1975.sp011103","volume":"251","author":"SW Kuffier","year":"1975","unstructured":"Kuffier SW, Yoshikami D (1975) The number of transmitter molecules in a quantum: an estimate from iontophoretic application of acetylcholine at the neuromuscular synapse. J Physiol 251: 465\u2013482","journal-title":"J Physiol"},{"key":"19_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/1531-8249(200009)48:3<391::AID-ANA17>3.0.CO;2-H","volume":"48","author":"DE Kuhl","year":"2000","unstructured":"Kuhl DE, Minoshima S, Frey KA, Foster NL, Kilbourn MR, Koeppe RA (2000) Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. Ann Neurol 48: 391\u2013395","journal-title":"Ann Neurol"},{"key":"19_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000051228","volume":"11","author":"S Lilienfeld","year":"2000","unstructured":"Lilienfeld S, Parys W (2000) Galantamine: additional benefits to patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord ll[Suppl 1]: 19\u201327","journal-title":"Dement Geriatr Cogn Disord"},{"key":"19_CR19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0031-6997(24)01406-6","volume":"51","author":"RJ Lukas","year":"1999","unstructured":"Lukas RJ, Changeux JP, Le Novere N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, Dani JA, Grady SR, Kellar KJ, Lindstrom JM, Marks MJ, Quik M, Taylor PW, Wonnacott S (1999) International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 51: 397\u2013401","journal-title":"Pharmacol Rev"},{"key":"19_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0006-3223(00)01109-4","volume":"49","author":"A Maelicke","year":"2001","unstructured":"Maelicke A, Samochocki M, Jostock R, Fehrenbacher A, Ludwig J, Albuquerque EX, Zerlin M (2001) Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer\u2019s disease. Biol Psychiatry 49: 279\u2013288","journal-title":"Biol Psychiatry"},{"key":"19_CR21","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1046\/j.1471-4159.1999.0731635.x","volume":"73","author":"CM Martin-Ruiz","year":"1999","unstructured":"Martin-Ruiz CM, Court JA, Molnar E, Lee M, Gotti C, Mamalaki A, Tsouloufis T, Tzartos S, Ballard C, Perry RH, Perry EK (1999) Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer\u2019s disease. J Neurochem 73: 1635\u20131640","journal-title":"J Neurochem"},{"key":"19_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0079-6123(08)62495-4","volume":"79","author":"A Nordberg","year":"1989","unstructured":"Nordberg A, Nilsson-Hakansson L, Adem A, Hardy J, Alafuzoff I, Lai Z, Herrera-Marschitz M, Winblad B (1989) The role of nicotinic receptors in the pathophysiology of Alzheimer\u2019s disease. Prog Brain Res 79: 353\u2013362","journal-title":"Prog Brain Res"},{"key":"19_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00002093-199505000-00006","volume":"9","author":"A Nordberg","year":"1995","unstructured":"Nordberg A, Lundqvist H, Hartvig P, Lilja A, Langstrom B (1995) Kinetic analysis of regional (S)(-) HC-nicotine binding in normal and Alzheimer brains \u00a1\u00aa in vivo assessment using positron emission tomography. Alzheimer Dis Assoc Disord 9: 21\u201327","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"19_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1358\/mf.2000.22.8.701373","volume":"22","author":"H Ogura","year":"2000","unstructured":"Ogura H, Kosasa T, Kuriya Y, Yamanishi Y (2000) Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Methods Find Exp Clin Pharmacol 22: 609\u2013613","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"19_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0014-2999(00)00009-1","volume":"393","author":"R Papke","year":"2000","unstructured":"Papke R.L., Meyer E., Nutter T., Uteshev V.V. (2000) a 7 receptor-selective agonists and modes of a 7 receptor activation. Eur J Pharmacol 393:179\u2013195","journal-title":"Eur J Pharmacol"},{"key":"19_CR26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(25)22435-1","volume":"270","author":"EF Pereira","year":"1994","unstructured":"Pereira EF, Alkondon M, Reinhardt S, Maelicke A, Peng X, Lindstrom J, Whiting P, Albuquerque EX (1994) Physostigmine and galanthamine: probes for a novel binding site on the alpha 4 beta 2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells. J Pharmacol Exp Ther 270: 768\u2013778","journal-title":"J Pharmacol Exp Ther"},{"key":"19_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0022-510X(77)90073-9","volume":"34","author":"EK Perry","year":"1977","unstructured":"Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE (1977) Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci 34: 247\u2013265","journal-title":"J Neurol Sci"},{"key":"19_CR28","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1212\/WNL.54.12.2261","volume":"54","author":"MA Raskind","year":"2000","unstructured":"Raskind MA, Peskind ER, Wessel T, Yuan W (2000) Galantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension. Neurology 54: 2261\u20132268","journal-title":"Neurology"},{"key":"19_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1034\/j.1600-0404.2000.00310.x","volume":"176","author":"M Samochocki","year":"2000","unstructured":"Samochocki M, Zerlin M, Jostock R, Groot Kormelink PJ, Luyten WH, Albuquerque EX, Maelicke A (2000) Galantamine is an allosterically potentiating ligand of the human alpha4\/beta2 nAChR. Acta Neurol Scand [Suppl] 176: 68\u201373","journal-title":"Acta Neurol Scand [Suppl]"},{"key":"19_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)08675-4","volume":"49","author":"A Schrattenholz","year":"1996","unstructured":"Schrattenholz A, Pereira EF, Roth U, Weber KH, Albuquerque EX, Maelicke A (1996) Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol Pharmacol 49: 1\u20136","journal-title":"Mol Pharmacol"},{"key":"19_CR31","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1212\/WNL.54.12.2269","volume":"54","author":"PN Tariot","year":"2000","unstructured":"Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilienfeld S, Ding C (2000) A 5-month, randomized, placebo-controlled trial of galantamine in AD. Neurology 54:2269\u20132276","journal-title":"Neurology"},{"key":"19_CR32","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/0024-3205(90)90429-U","volume":"46","author":"T Thomsen","year":"1990","unstructured":"Thomsen T, Kewitz H (1990) Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo. Life Sci 46: 1553\u20131558","journal-title":"Life Sci"},{"key":"19_CR33","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1212\/WNL.55.9.1278","volume":"55","author":"P Tiraboschi","year":"2000","unstructured":"Tiraboschi P, Hansen LA, Alford M, Masliah E, Thai LJ, Corey-Bloom J (2000) The decline in synapses and cholinergic activity is asynchronous in Alzheimer\u2019s disease. Neurology 55: 1278\u20131283","journal-title":"Neurology"},{"key":"19_CR34","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1136\/bmj.321.7274.1445","volume":"321","author":"GK Wilcock","year":"2000","unstructured":"Wilcock GK, Lilienfeld S, Gaens E (2000) Efficacy and safety of galantamine in patients with mild to moderate Alzheimer\u2019s disease: multicentre randomised controlled trial. BMJ 321: 1445\u20131449","journal-title":"BMJ"}],"container-title":["Journal of Neural Transmission. Supplementa","Ageing and Dementia Current and Future Concepts"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7091-6139-5_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T03:32:26Z","timestamp":1741145546000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-7091-6139-5_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"ISBN":["9783211837962","9783709161395"],"references-count":34,"URL":"https:\/\/doi.org\/10.1007\/978-3-7091-6139-5_19","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-7091-6139-5","asserted-by":"object"}]},"ISSN":["0303-6995"],"issn-type":[{"value":"0303-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}